2019 Medicare Advantage Plans in
Richland County Illinois
There are 14 Medicare Advantage Plans available in Richland County IL from 3 different health insurance providers. 0 of these Medicare Advantage plans offer additional gap coverage. The plan with the lowest out of pocket expense is $4000 and the highest out of pocket is $6700. Richland County Illinois residents can also pick from 0 Medicare Special Needs Plans. The highest rated plan available in Richland County received a 4 overall star rating from CMS and the lowest rated plan is 3.5 stars
(Click the Plan Name for More Details)
(⇅ Click the Header to Sort)
|Health Alliance Medicare HMO 20 Rx (HMO)
|Health Alliance Medicare HMO 40 Rx (HMO)
|Health Alliance Medicare HMO Basic Rx (HMO)
|Health Alliance Medicare POS 10 Rx (HMO-POS)
|Health Alliance Medicare POS 30 Rx (HMO-POS)
|Health Alliance Medicare POS Basic Rx (HMO-POS)
|Humana Gold Choice H8145-008 (PFFS)
|HumanaChoice H5216-013 (PPO)
|HumanaChoice R5361-002 (Regional PPO)
Medicare Advantage Health Plans Without Drug Coverage
|Plan Name ⇅||Premium||Type||MOOP||Overall
|Health Alliance Medicare HMO Basic (HMO)
||$0||Local HMO *||$6,700|
|Health Alliance Medicare POS Basic (HMO-POS)
||$23.00||Local HMO *||$6,700|
|Humana Gold Choice H8145-121 (PFFS)
|HumanaChoice R5361-001 (Regional PPO)
||$0||Regional PPO *||$6,700||Enroll|
|Lasso Healthcare (MSA)
Plan Type Is the type of organization offering the Medicare Plans.
- HMO - Health Maintenance Organization
- PPO - Preferred Provider Organization
- PDP - Prescription Drug Plan
- SNP - Special Needs Plan
- POS - Point of Service
- PFFS - Private Fee For Service
- (DS) Defined Standard Benefit
- (BA) Basic Alternative
- (AE) Actuarially Equivalent Standard
Star Rating as of October 10, 2018.
For More Information on Ratings Please See the CMS Tech Notes.
Plans are subject to change as contracts are finalized.
Includes 2019 approved contracts. Employer sponsored 800 series and plans under sanction are excluded. For 2019, enhanced alternative may offer additional cost sharing reductions in the gap on a sub-set of the formulary drugs, beyond the standard Part-D benefit.